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Abstract
 
Peptide fragments of self-proteins bound to major histocompatibility complex molecules
within the thymus are important for positively selecting T cell receptor (TCR)-bearing
CD4
 
 
 
CD8
 
 
 
 double positive (DP) thymocytes for further maturation. The relationship be-
tween naturally processed thymic self-peptides and TCR-specific cognate peptides is un-
known. Here we employ HPLC purification of peptides released from H-2K
 
b
 
 molecules of the
C57BL/6 thymus in conjunction with mass spectrometry (MS) and functional profiling to
identify a naturally processed K
 
b
 
-bound peptide positively selecting the N15 TCR specific for
the vesicular stomatitis virus octapeptide (VSV8) bound to K
 
b
 
. The selecting peptide was iden-
tified in 1 of 80 HPLC fractions and shown by tandem MS (MS/MS) sequencing to corre-
spond to residues 68–75 of the MLRQ subunit of the widely expressed mitochondrial NADH
ubiquinone oxidoreductase (NUbO
 
68–75
 
). Of note, the peptide differs at six of its eight residues
from the cognate peptide VSV8 and functions as a weak agonist for mature CD8 single positive
(SP) N15 T cells, with activity 10,000-fold less than VSV8. In N15 transgenic (tg) recombinase
activating gene 2
 
 
 
/
 
  
 
transporter associated with antigen processing 1
 
 
 
/
 
 
 
 fetal thymic organ cul-
ture, NUbO
 
68–75 
 
induces phenotypic and functional differentiation of N15 TCR bearing CD8
SP thymocytes. Failure of NUbO
 
68–75
 
 to support differentiation of a second K
 
b
 
-restricted TCR
indicates that its inductive effects are not general.
Key words: positive selection • thymocyte development • CTL • naturally processed peptides • 
TAP-1
 
 
 
/
 
 
 
Introduction
 
TCRs are generated in the thymus through a recombina-
torial mechanism involving rearrangement of TCR 
 
 
 
 and
 
 
 
 genes, thereby creating a diverse array of receptor speci-
ficities (for a review, see reference 1). Thymocytes bearing
TCRs useful to the organism are maintained, whereas
those displaying potentially harmful autoreactive specifici-
ties are deleted. The process termed positive selection en-
riches for thymocytes with valuable TCR specificities, i.e.,
ones recognizing foreign peptides (viral, bacterial, tumor,
etc.) bound to self-MHC molecules (2–7). In contrast,
negative selection removes autoreactive thymocytes through
an apoptotic process (8). Collectively, these two selection
processes shape the repertoire of T cells in a given or-
ganism.
That T cells preferentially recognize peptides in associa-
tion with MHC molecules from the thymus within which
those same T cells developed was the basis for the idea of
positive selection (3, 7). Previously, the role of peptides in
the positive selection process was unidentified. However,
recent studies of T cell development in animals harboring
natural mutations in MHC molecules showed positive se-
lection requires peptides (9–11). This conclusion was inde-
pendently confirmed by experimental approaches using fe-
tal thymic organ cultures (FTOCs) and MHC-deficient
animals (12–15). Positively selecting ligands may be dis-
tinct in sequence from the cognate peptides or alterna-
tively, quite similar with only subtle differences at single
amino acid positions (16–20). In some studies, only pep-
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tide variants with antagonistic functional activity have been
found to be positively selecting (21, 22), while in other ex-
amples, the positively selecting peptide has been a weak
agonist (16, 20, 23, 24). The latter studies suggest that a
given peptide can function as a positively selecting ligand
at one concentration and a negatively selecting ligand at a
higher concentration (21, 24). Despite this complexity,
arising perhaps from variation in TCR transgenes and/
or MHC-deficient backgrounds used to examine these
processes (transporter associated with antigen processing
[TAP]
 
*
 
 
 
/
 
 
 
 versus 
 
 
 
2M
 
 
 
/
 
 
 
), one overwhelming consensus
exists: MHC-complexed peptides (pMHC) which enhance
affinity for a TCR interaction induce negative selection
compared with peptides in complex with the same MHC
that show weaker affinity for that TCR. Moreover, those
pMHC complexes with faster TCR off-rates may be more
favorable at inducing positive selection than those with
slower off-rates (25, 26). Presumably, the weaker affinities
of positively selecting pMHC ligands trigger survival sig-
nals and, unlike the negatively selecting TCR ligands, fail
to activate the apoptotic program of the double positive
(DP) thymocyte.
Efforts to identify naturally processed self-peptide ligands
fostering thymocyte development would aid in the under-
standing of positive selection. Moreover, such information
would help to delineate distinctions between selecting ver-
sus antigenic peptides. To date, analysis of natural peptides
has used tumor cells or thymic epithelial cell lines as a se-
lecting peptide source; although informative, the nature of
thymic peptides must be inferred (17, 18, 27). To identify
the number and nature of positively selecting peptidic
components within the thymus of a normal animal, this
study was conducted using the well-defined N15 TCR
transgenic (tg) recombinase activating gene (RAG)-2
 
 
 
/
 
 
 
H-2
 
b
 
 system and C57BL/6 thymic peptides. Here we show
that (i) a positively selecting peptide could be identified
among 80 pools of peptides eluted from thymic K
 
b
 
 in
C57BL/6 mice, (ii) this peptide bears virtually no sequence
identity to VSV8 but is an abundant constituent of K
 
b
 
complexes in the B6 thymus, being derived from the mi-
tochondrial enzyme NADH ubiquinone oxidoreductase
(NUbO
 
68–75
 
), and (iii) NUbO
 
68–75 
 
represents an extremely
weak functional agonist for mature N15 TCR-expressing
CD8 single positive (SP) peripheral T cells.
 
Materials and Methods
 
Mice.
 
N15 TCRtg RAG-2
 
 
 
/
 
 
 
 H-2
 
b
 
, N15 TCR tg RAG-
2
 
 
 
/
 
 
 
 
 
 
 
2
 
M
 
 
 
/
 
 
 
 H-2
 
b
 
, and N15 TCRtg RAG-2
 
 
 
/
 
 
 
 TAP-1
 
 
 
/
 
 
 
H-2
 
b
 
 mice were generated as described previously (28). C57BL/6
TAP-1
 
 
 
/
 
 
 
 mice were purchased from Taconic. The lack of
RAG-2, 
 
 
 
2
 
M, or TAP-1 gene expression in knockout animals
was identified based on the FACS
 
®
 
 analysis of peripheral blood
cells and Southern blotting or PCR on genomic DNA (28). The
homozygosity of the N15 TCR transgenes was proven by subse-
quent breeding analysis. All lines were maintained and bred un-
der sterile barrier conditions at the animal facility of Dana-Farber
Cancer Institute.
 
Peptide Synthesis.
 
Peptides were synthesized by standard solid
phase methods on an Applied Biosystems 430A synthesizer at the
Biopolymers Laboratory of Massachusetts Institute of Technol-
ogy. All peptides were purified by reverse phase HPLC (HPLC
1100; Hewlett Packard) with a C4 2-mm column. Peptides were
analyzed for purity and correct molecular weight by electrospray
mass spectrometry (MS), amino acid analysis, and HPLC.
 
Abs and Flow Cytometric Analysis.
 
The following mAbs were
used: R-phycoerythrin anti–mouse CD4 (H129.19) and FITC
anti–mouse CD8
 
 
 
 (53-6.7; BD PharMingen). For flow cytome-
try, single cell thymocyte suspensions were prepared in PBS con-
taining 2% FCS and 0.05% NaN
 
3
 
. Thymocytes were stained at
5 
 
  
 
10
 
6
 
 cells per milliliter in PBS, 2% FCS and 0.05% NaN
 
3 
 
con-
taining the Abs at saturating concentrations. Phenotypes and pro-
portions of thymocyte subsets were analyzed by two-color flow
cytometry using FACScan™ (Becton Dickinson) and the
CELLQuest™ program. Dead cells were excluded from the anal-
ysis by forward and side scatter gating.
 
DP Dulling Assay.
 
Peritoneal exudate cells (PECs) from
TAP-1
 
 
 
/
 
 
 
 H-2
 
b
 
 mice, induced 5 d previously with 2 ml of 3%
thioglycollate, were suspended in AIM-V medium (Life Tech-
nologies) containing 50 
 
 
 
M 2-ME and plated at 10
 
5
 
 per well in a
96-well microtiter plate. After adherence for 2 h, monolayers
were washed with AIM-V medium four times. Thymocytes (5 
 
 
 
10
 
5
 
) from 4–6-wk-old N15tg RAG-2
 
 
 
/
 
  
 
 
 
2
 
M
 
 
 
/
 
  
 
H-2
 
b
 
 mice
were cocultured with each HPLC purified thymic H-2K
 
b
 
–
derived fraction or synthetic peptide plus PEC for 18 h at 37
 
 
 
C,
and stained for the expression of CD4 and CD8
 
 
 
.
 
Extraction of Self-Peptides from K
 
b
 
 Molecules.
 
K
 
b
 
 molecules
were immunoprecipitated essentially as described previously
(29). In brief, thymi from 50 C57BL/6 mice were lysed with 50
ml of buffer containing 20 mM Tris, pH 8.0, 150 mM NaCl,
0.5% NP-40, 20 
 
 
 
g/ml aprotinin, 10 
 
 
 
g/ml leupeptin, 1 mM
PMSF, 10 
 
 
 
g/ml pepstatin, 1 mM EDTA and 0.05% sodium
azide, and insoluble material was removed by centrifugation.
The cell lysate was incubated overnight with 2.0 ml of Protein A
beads covalently coupled with the anti–H-2K
 
b
 
 mAb, Y3, at 5
mg/ml. After eight washes, the immunoprecipitate was eluted by
treatment with 5 ml of 0.1 N acetic acid, pH 3.0, and denatured
by boiling for 10 min in 10% acetic acid. Low molecular weight
material was collected by passage over a 10,000 MW cut-off
membrane (Microcon 10; Millipore). After concentration to the
volume of 20 
 
 
 
l, the material was resuspended in 150 
 
 
 
l of H
 
2
 
O
containing 0.1% TFA. HPLC fractionation was carried out on a
Varian model 9012 instrument, using a Rainin C18 column (Mi-
crosorb 100Å, 5 
 
 
 
m, 15 cmL; Varian Chromatography Systems).
The initial buffer system consisted of A and B, which were 0.1%
TFA in deionized water and 0.1% TFA in acetonitrile, respec-
tively. A linear gradient from 0–80% buffer B was used 
 
 
 
40
min. The flow rate was 0.2 milliliter per min and fractions were
collected at 0.5 min intervals (100 
 
 
 
l per fraction). 80 
 
 
 
l of the
fractionated samples were lyophilized and resuspended in H
 
2
 
O
before biological analyses.
 
Sequence Determination of Peptides.
 
Sequence information was
determined by microcapillary reverse-phase chromatography di-
rectly coupled to a Finnigan LCQ quadrupole ion trap mass spec-
trometer equipped with a custom nanoelectrospray source. The
column was packed in-house with 5 cm of C18 support into a
 
*
 
Abbreviations used in this paper: 
 
DP, double positive; FTOC, fetal thymic
organ culture; MS, mass spectrometry; MS/MS, tandem MS; PEC, peri-
toneal exudate cell; pMHC, peptide–MHC complex; RAG, recombinase
activating gene; SP, single positive; TAP, transporter associated with anti-
gen processing; tg, transgenic. 
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New Objective one-piece 75-
 
 
 
m column terminating in an
8.5-
 
 
 
m tip. Flow rate was a nominal 200 nanoliters per min. The
ion trap was programmed to acquire successive sets of three scan
modes consisting of full scan MS of 395–1,300 m/z, followed by
two data dependent scans on the most abundant ion in those full
scans. These dependent scans allowed the automatic acquisition
of a high resolution (zoom) scan to determine charge state and
exact mass, and tandem MS (MS/MS) spectra for peptide se-
quence information. MS/MS spectra were acquired with a rela-
tive collision energy of 30–35%, an isolation width of 2.5 daltons
and recurring ions dynamically excluded. De novo
 
 
 
sequence in-
terpretation of the resulting MS/MS spectra was facilitated by the
program FuzzyIons developed in the Harvard Microchemistry
Facility and the SEQUEST algorithm (30, 31).
 
FTOC.
 
Fetuses of N15tg RAG-2
 
 
 
/
 
  
 
TAP-1
 
 
 
/
 
 
 
 H-2
 
b
 
 mice
were dissected at day 16.5 (plug 
 
 
 
 day 1) and fetal thymic lobes
were cultured with or without the indicated peptides in AIM-V
medium containing 50 
 
 
 
M 2-ME as described previously (20,
32). The medium was replaced every 48 h. After 7 d, thymocytes
were stained for the expression of CD4 and CD8
 
 
 
, or were
tested for their capacity to respond to antigen in a 2-d prolifera-
tion assay, as described below.
 
Proliferation Assay.
 
Thymocytes from the organ cultures or
fresh LN cells from N15tg
 
 
 
RAG-2
 
 
 
/
 
 
 
 H-2
 
b
 
 mice (10
 
5
 
 cells per
well) were incubated at 37
 
 
 
C with 2 
 
 
 
 10
 
4
 
 irradiated EL-4 cells,
which were preloaded for 2 h with the indicated doses of pep-
tides in AIM-V medium containing 50 
 
 
 
M 2-ME with or with-
out 100 U/ml rIL-2. After 48 h of incubation, 0.4 
 
 
 
Ci per well
of 
 
3
 
H-TdR (ICN Biomedicals) were added, and after an addi-
tional 18 h of culture at 37
 
 
 
C, the cells were harvested and the
incorporated radioactivity was measured.
 
RMA-S H-2K
 
b
 
 Stabilization Assay.
 
RMA-S cells were incu-
bated for 18 h at 27
 
 
 
C in RPMI 1640 medium containing 10%
FCS to induce H-2K
 
b
 
 expression (33). A total of 10
 
 
 
12
 
–10
 
 
 
4
 
 M
of each peptide was added to 106 RMA-S cells in 1 ml final vol-
ume of the RPMI 1640 medium containing 1% FCS. After an
additional 1 h incubation at 37 C, the cells were moved to a
37 C incubator. After 4 h of incubation at 37 C, cells were
washed, subdivided, and stained in parallel with an excess of the
anti–H-2Kb mAb, HB 158 (AF6-88.5.3) and Y3, followed by
FITC-conjugated goat anti–mouse IgG Ab. Fluorescence of
stained cells was determined on a FACScan™ and analyzed with
CELLQuest™ software.
Results
Analysis of Naturally Processed, Kb-bound Thymic Self-Pep-
tides. To characterize those endogenous peptides from
the C57BL/6 thymus able to positively select a TCR with
a foreign peptide specificity, we employed the N15 TCR
tg RAG-2 /  H-2b mouse system. In this mouse, CD8 SP
T lymphocytes bearing the TCR of the N15 CTL clone
recognize the foreign vesicular stomatitis virus nucleopro-
tein amino acids 52–59 (VSV8)(RGYVYQGL) bound to
the MHC class I molecule, H-2Kb. This viral peptide in
complex with H-2Kb is the major determinant against
which protective CTLs are generated in the C57BL/6
mouse. On the RAG-2 /  background, N15 is the only
TCR expressed, thereby allowing unambiguous analysis of
cell fate in the N15 TCR tg RAG-2 /  H-2b background.
For these experiments, Kb molecules were immunoaffinity
purified from NP40-lysed thymii of C57BL/6 mice using
the anti-Kb mAb Y3. Subsequently, peptides bound to
Sepharose-associated Kb molecules were retrieved by acid
denaturation followed by passage over a 10,000-MW cut-
off membrane to remove nonpeptidic components. The
peptides were further separated based on their hydrophobic
characteristics by reverse-phase HPLC using a C18 column
(Fig. 1 A, top) and an aliquot of each HPLC fraction was
tested for its ability to interact with the N15 TCR in bio-
logical assays (Fig. 1 A, bottom). Although FTOC has been
Figure 1. Biochemical fractionation and DP thymocyte dulling bioas-
say of peptides eluted from C57BL/6 thymic Kb molecules. (A) Detection
of an HPLC fraction that promotes DP dulling in N15 tg RAG-2 / 
 2M /  H-2b thymocytes. Each of 80 HPLC-separated fractions of natu-
ral peptides eluted from the H-2Kb molecules from C57BL/6 thymii was
tested in a dulling assay. The chromatograph of peptides eluted (shown as
214 nm absorbance U) from H-2Kb molecules of C57BL/6 murine
thymii (top) and the DP dulling activity (shown as a percentage of cells
with a CD4/CD8 staining lower than controls) (bottom) of each fraction
are shown. DP dulling activity is expressed as the percentage of DP cells
with a reduction in the expression of CD4 and CD8 , thus resulting in
immunofluorescence outside the specified DP thymocyte gate. The per-
centages of DP cells with CD4/CD8 dulling in cultures with 1 nM L4
peptide, a known weak agonist for the N15 TCR, or no peptides, were
37.5 and 11.4%, respectively. Arrows show a single fraction positive for
DP dulling activity. (B) The CD4 versus CD8 staining profile of total
thymocytes is shown after treatment with 80% of the material from the
positive fraction (fraction 33.5), a representative adjacent negative fraction
(fraction 32) or an equivalent volume of 1 nM synthetic L4 peptide.
“None” is a control histogram containing thymocytes plus PECs cultured
in the absence of any exogenous peptide additions.886 Thymic Self-Peptide and Selection
used to identify peptides that have the capacity to induce
positive selection of thymocytes bearing various TCR
transgenes, this assay is not convenient for screening self-
peptides extracted from cells or tissues since large amounts
of material are required. Thus, to screen complex mixtures
of self-peptides, we used a previously described DP thy-
mocyte dulling assay (17) to determine the potential inter-
action of the TCR expressed on immature thymocytes
with peptides complexed with a given MHC molecule on
the surface of APCs. For this purpose, N15 tg RAG-2 / 
 2M /  thymocytes were cultured in vitro for 18 h with
PECs from TAP-1 /  mice preincubated with HPLC-
fractionated mixtures of purified self-peptides. In this assay,
TCR interaction with pMHC ligands is detected as a re-
duction of the intensity of CD4 and CD8 expression on
the surface of DP thymocytes.
As shown in Fig. 1 B, dulling is observed with a positive
synthetic peptide control, termed L4 (RGYLYQGL), a
weak agonistic altered peptide ligand of the cognate VSV8
peptide (16, 20). The percentage of DP thymocytes de-
creases from 46.8 to 29.9 after treatment with 1 nM L4 rel-
ative to the no peptide addition control. Although not
shown, with an unrelated Kb-binding peptide SEV9, DP
dulling activity is not observed at any peptide concentra-
tion tested despite its binding to Kb with affinity compara-
ble to L4 or VSV8 (Fig. 3 C). Thus, the potency of the
dulling effect depends upon specific TCR recognition,
varying with individual peptides as reported previously
(17). Using this assay, we screened 80 HPLC fractions de-
rived from the C57BL/6 thymic Kb-bound peptide mix-
ture. As shown by the functional dulling activity profiled in
Fig. 1 A (bottom), a single fraction was identified as posi-
tive for DP dulling activity. The subtle but significant re-
duction in the intensity of the CD4 and CD8 expression
on the surface of the N15 tg RAG-2 /   2M /  DP thy-
mocytes observed after exposure to HPLC fraction 33.5 is
seen in Fig. 1 B. After addition of other fractions of which
fraction 32 is representative, no significant dulling was ob-
served over the baseline “no peptide” addition. These find-
ings suggest there are a finite number of naturally processed
positively selecting peptides within the thymus for the N15
TCR. Consistent with this notion, we failed to identify
any peptides eluting from the Kb molecules of the EL-4 tu-
mor cell line active in this assay, aside from the cognate
VSV8 peptide spiked into the EL-4–derived natural pep-
tide mix (data not shown).
Identification of a Mitochondrial Enzyme Component as a
Source of Self-Peptide. To identify the peptide responsible
for the fraction 33.5 dulling activity, an aliquot of the pool
(20%) was subject to sequencing by the ion trap MS/MS. A
sequence from a doubly charged precursor of m/z   469.3
was determined to be VNVDYS[K/Q][L/I]. Note the iso-
baric possibilities at each of the COOH-terminal p7 and p8
residues preclude unambiguous assignment at those two
positions. However, SEQUEST analysis (31, 34) identified
a match with a known murine protein, NADH ubiqui-
none oxidoreductase MLRQ subunit at residues 68–75
(NUbO68–75) (VNVDYSKL). NUbO is a nuclear-encoded
mitochondrial protein component of complex 1 of the
NADH ubiquinone complex and is widely expressed in
various tissues (35). Importantly, the sequence contains a
characteristic hydrophilic Kb anchor residue at p3 (V), p5
(Y), and p8 (L). To verify that the spectrum of the peptide
in fraction 33.5 matched that of VNVDYSKL, a synthetic
peptide corresponding to the deduced sequence was syn-
thesized and its MS/MS spectrum compared. As shown in
Fig. 2, the two spectra are indistinguishable, providing
strong evidence for the identity of the fraction 33.5 pep-
tide.
The NUbO68–75/Kb Complex Interacts with the N15 TCR
on Immature Thymocytes and Mature T Cells. To next test
the functional activity of the constituent identified by MS,
the synthetic NUbO68–75 peptide was tested in DP dulling
assays of immature N15 TCR-bearing thymocytes. As
shown in Fig. 3 A, the NUbO68–75 peptide induces signifi-
cant DP dulling activity, reducing the percentages of DP
Figure 2. Identification of the peptide sequence from
the HPLC fraction positive for the DP dulling activity.
Comparison of the MS/MS spectra from fraction 33.5
with that of a synthetic peptide of the sequence NUbO68–75.
Relative collision energy was 30 and 35%, respectively.887 Sasada et al.
thymocytes from 73 to 16%, 34 and 61% at 10  M, 1  M
and 100 nM peptide concentrations, respectively. The ac-
tivity in fraction 33.5 corresponds to a NUbO68–75 concen-
tration  100 nM (compare Figs. 3 A and 1 B). To examine
the ability of NUbO68–75 peptide to stimulate proliferation
of mature CD8 N15 TCR-bearing T cells, LN cells from
N15 tg RAG-2 /  H-2b mice were cultured with varying
molar concentrations of the synthetic NUbO68–75 peptide
using irradiated EL-4 cells as Kb-bearing APCs. After 48 h
of stimulation, cells were pulsed with 3H-TdR and the
mean incorporation of duplicate cultures determined. As
shown in Fig. 3 B, the cognate peptide VSV8 maximally
stimulated 3H-TdR incorporation at  100 pM-1 nM. In
contrast, the NUbO68–75 peptide requires a 10- M peptide
concentration to stimulate maximal proliferation. Thus, the
identified NUbO68–75 peptide is a weak agonist on mature
peripheral N15 T cells, differing by  10,000 fold from
VSV8. This level of agonist activity is comparable to L4
and clearly detectable, unlike with OVAp where no stimu-
lating activity is observed even at a peptide concentration
of 0.1 mM. The weak agonist activity of NUbO68–75 is not
a consequence of poor Kb binding as shown by the RMA-S
binding assay (Fig. 3 C). The concentration of NUbO68–75
required to yield half-maximal Kb surface expression is less
than that of VSV8.
Thymic Selection Mediated by NUbO68–75. While the
above dulling assay offers a sensitive means to detect TCR–
pMHC interaction involving thymocytes and APCs, it
does not provide direct information about the ability of the
peptides to mediate positive versus negative selection. To
ascertain such activity, both in vivo and in vitro assays were
performed. Individual N15 tg RAG-2 /  H-2b mice were
injected intravenously with 20  g of VSV8 or NUbO68–75
peptide and the surviving subset of thymocytes examined
after 24 h. As shown in Fig. 4, the majority of DP thy-
mocytes are deleted after injection of the VSV8 cognate
peptide. Previous studies showed that this deletion involves
a caspase-dependent apoptotic mechanism (32). However,
NUbO68–75 peptide induced no detectable deletion in the
DP thymocyte subset in these mice.
To further investigate whether NUbO68–75 might induce
positive selection of DP thymocytes, we performed FTOC
analysis using N15 tg RAG-2 /  TAP-1 /  thymus lobes
cultured in synthetic media with or without the NUbO68–75
peptide. For comparison, parallel cultures of fetal thymic
lobes from N15 tg RAG-2 /  TAP-1 /  were performed.
As shown in Fig. 5 A, in the normal H-2b MHC back-
ground, N15 tg RAG-2 /  TAP-1 / , 19% of thymocytes
mature into CD8 SP cells whereas in the MHC class I–defi-
cient FTOC, N15 tg RAG-2 /  TAP-1 / , this percent-
Figure 3. NUbO68–75 peptide interacts with N15 TCRs
on immature thymocytes and peripheral mature T cells.
(A) N15 tg RAG-2 /   2M /  H-2b thymocytes were
cultured for 18 h with PECs from TAP-1 /  mice in the
presence of the various concentrations of NUbO68–75 pep-
tide. Alterations in the expression of CD4 (y axis) and
CD8  (x axis) on DP thymocytes were detected by flow
cytometry after gating on 10,000 live cells. The percentage
of cells in each DP gate is indicated. “None” is a control
dot plot containing thymocytes plus PEC cultured in the
absence of any exogenous peptide. (B) Proliferation assay
of LN cells from N15 tg RAG-2 /  H-2b mice cultured
with various concentrations of the indicated peptides and
irradiated Kb-bearing EL-4 cells. Mean of duplicate sam-
ples is shown. (C) RMA-S immunofluorescence assay us-
ing the Kb-specific mAb HB 158 and indicated peptides at
specific molar concentrations. Comparable results were
observed with the Y3 mAb as well (data not shown).888 Thymic Self-Peptide and Selection
age is reduced by 50%. With addition of 1  M NUbO68–75,
however, the percentage of CD8 SP thymocytes is re-
stored. Moreover, at 10  M NUbO68–75 there is a 5–6-fold
increase in the percentage of CD8 SP thymocytes which
does not rise further with 100  M NUbO68–75. Perhaps
more important, Fig. 5 B demonstrates that the phenotypic
increase in SP thymocytes induced by 10  M NUbO68–75
is accompanied by functional maturation. Hence, if FTOC
is established in the presence of 10  M NUbO68–75 for 7 d,
the subsequent immune response of the harvested thy-
mocytes to the VSV8 peptide or the weak L4 variant ago-
nist is increased as judged by cellular proliferation. Further-
more, although 100  M NUbO68–75 also showed a
prominent increase in the percentage of the CD8 SP thy-
mocyte subset (55%), the total cellularity of the thymus is
reduced and the increase in CD8 SP thymocyte number is
not significant (Fig. 5 A and see legend). Although not
shown, propidium iodide staining of thymocytes after 7 d
of culture with NUbO68–75 showed a significant increase in
apoptotic cells in the DP thymocyte subset only at 100
 M. Thus, NUbO68–75 induces negative rather than posi-
tive selection in N15-bearing immature thymocytes at 100
 M. Consistent with the thymocyte phenotype, little pro-
liferation is observed to VSV8 or L4 by thymocytes har-
vested from FTOCs after culture with 100  M NUbO68–75
(data not shown). These results suggest that NUbO68–75
functions as both a positive and a negative selecting peptide
ligand for N15 TCR, depending on the density of pMHC
in the thymic environment and consistent with the avidity
model (23).
Discussion
To identify a naturally occurring, thymic peptide(s) re-
sponsible for thymic selection of the VSV8/Kb-specific
N15 TCR, peptides from immunoaffinity purified Kb mol-
ecules of 50 C57BL/6 (H-2b) thymii were eluted, fraction-
ated by reverse-phase HPLC, and tested in dulling assays
using N15 tg RAG-2 /    2M /  H-2b thymocytes. A
single mitochondrial protein (MLRQ)-derived peptide,
NUbO68–75, was identified, synthesized, and shown to pos-
Figure 4. Peptide injection of in vivo VSV8 but not NUbO68–75 in-
duces negative selection in DP thymocytes from N15 RAG-2 /  H-2b
mice. 20  g of VSV8 or NUbO68–75 were injected into the tail vein of
3-wk-old N15 tg RAG-2 /  H-2b mice. 24 h after peptide injection, the
expression of CD4 (y axis) and CD8  (x axis) in thymocytes was detected
by two-color flow cytometry gating on live cells. The percentages of re-
maining DP thymocytes are indicated with “none” referring to injection
of PBS.
Figure 5. NUbO68–75 induces positive selection of N15 tg RAG-2 / 
TAP-1 /  H-2b thymocytes. FTOC was performed by using N15 tg
RAG-2 /  TAP-1 /  H-2b thymic lobes in AIM-V medium with 1, 10,
or 100  M NUbO68–75. For comparison, FTOC was performed with
N15 tg RAG-2 /  TAP-1 /  H-2b as well. After 7 d, thymocytes were
released from the lobes by passing through a steel mesh and cell numbers
were counted. (A) The CD4 (y axis) versus CD8  (x axis) staining pro-
files of total thymocytes after FTOC are shown for the indicated culture
conditions with the percentage of CD8 SP thymocytes indicated. The ab-
solute numbers (mean   SD) of CD8 SP thymocytes after FTOC of N15
tg RAG-2 /  TAP-1 /  H-2b with 100  M, 10  M, 1  M NUbO68–75,
or no peptide were: 0.87   0.37   105 (n   7); 1.81   0.32   105 (n  
6); 0.83   0.09   105 (n   4); or 0.69   0.08   105 (n   6); respec-
tively. The absolute number of CD8 SP thymocytes from FTOC of N15
tg RAG-2 /  TAP-1 /  H-2b was 1.26   0.23   105 (n   12). Al-
though not shown, TCR expression as judged by the R53 anticlonotype
or H57 anti-C  mAb reactivity is increased 5–10 fold on CD8 SP thy-
mocytes relative to DP thymocytes (16). (B) Thymocytes selected on
NUbO68–75 peptide are functionally responsive to VSV8 and L4. Thy-
mocytes from the above organ cultures with 10  M NUbO68–75 were as-
sayed for their proliferative response to 2   104 irradiated EL-4 cells in
the presence of 10 nM VSV8, 10  M L4, or no peptide. 3H-TdR incor-
poration was determined after 48 h. Results are shown as mean   SD of
triplicate cultures.889 Sasada et al.
sess measurable biological activity. The MS/MS fingerprint
of this synthetic peptide was identical to the functionally
active HPLC thymic peptide fraction. NUbO68–75 mediates
positive selection of the N15 TCR in N15 RAG-2 / 
TAP-1 /  H-2b FTOC at 1–10  M concentrations. At the
same time, NUbO68–75 does not mediate negative selection
upon in vivo injection of N15 tg RAG-2 /  H-2b mice
while the VSV8 cognate peptide induces prompt DP thy-
mocyte deletion at the same dose. For mature N15 CD8
SP T cells, NUbO68–75 is a 10,000-fold weaker agonist than
VSV8 in molar terms, consistent with the notion that posi-
tively selecting peptides have substantially poorer affinities
than their cognate peptide counterparts or other full ago-
nists (19, 25). In this regard, earlier studies with synthetic
peptides demonstrated that VSV8 and I4 are strong agonists
for the N15 TCR and induce negative selection while L4
is a weak agonist and induces positive selection (16, 20).
Characterization of NUbO68–75 represents the first iden-
tification of a naturally processed self-peptide extracted
from normal thymus with selecting ability for a TCR.
Whether NUbO68–75 is bound to Kb molecules on stromal
elements, thymocytes, or both is unclear. Notwithstanding,
these current data must be interpreted in the context of
earlier studies using cell lines as a source for isolating poten-
tial selecting peptides. For example, using the OT-1 TCR
specific for OVAp-Kb pMHC and Kb-bearing LB27 tumor
cells as a source of Kb-bound peptides, Hogquist et al. (17)
identified OT-1 TCR dulling activity in 8 out of 100
HPLC fractions. Of several peptides sequenced, one, de-
rived from F-actin capping protein subunit  1 (CP 192–99),
showed dulling activity, and mediated positive selection in
OT-1 TAP-1 /  H-2b FTOCs. Likewise, using tg mice
expressing the F5 TCR specific for influenza virus 68
nucleoprotein366–374/Db pMHC or the P14 TCR specific
for lymphocytic choreomeningitis virus glycoprotein pep-
tide33–41/Db pMHC in conjunction with the thymic epi-
thelial cell line 427.1, several positively selecting peptides
were identified (18). F5 TCR-bearing thymocytes were
positively selected in F5 tg TAP-1 /  FTOC by mouse
histone H2A.176–84 or mouse brain protein E46100–108
whereas P14 TCR-bearing thymocytes were positively se-
lected in P14 TAP-1 /  FTOC by mouse ribonucleotide
reductase M1634–642 but not by H2A.176–84 or E46100–108. A
common feature to each of these positively selecting pep-
tides is their derivation from a widely expressed protein in-
volved in basic cellular functions. For example, NUbO68–75
is one of the four multisubunit enzyme complexes com-
prising the mitochondrial electron transport chain; CP 1 is
derived from an F-actin capping protein subunit integral to
the cellular cytoskeleton and ribonucleotide reductase M1
is essential for cell division. All of these proteins, including
the brain protein E46, are expressed in thymus. In the cel-
lular sources examined, their derivative fragments represent
a significant component of the naturally processed peptide
pool. Of note, the alloreactive 2C CTL clone recognizes
two distinct specificities, P2 Ca/Ld and dEV-8/Kbm3 (27).
The latter pMHC ligand includes the dEV-8 peptide
which also derives from mouse MLRQ. In fact, the p8 va-
line residue of dEV-8 is the p1 residue of NUbO68–75, im-
plying that the small ( 100 amino acids) MLRQ gene
product may be processed endogenously into several MHC
class I–binding fragments. The P2 Ca peptide is also a mi-
tochondrial protein derivative. Although thymus-specific
selecting peptides may exist in the context of one or an-
other cell type-specific stromal element, these are not ap-
parently the common selecting peptides based on this lim-
ited sampling to date of MHC class I–bound peptides. In
the case of MHC class II, comparison of endogenous pep-
tides bound to splenic and thymic MHC molecules also
supports this view (36).
Another common feature of naturally derived and posi-
tively selecting ligands is their extremely remote, even
nonexistent, similarity to the cognate antigen for which a
given TCR is specific. For example, in the case of the N15
TCR, the VSV8 ligand (RGYVYQGL) bears identity to
NUbO68–75 (VNVDYSKL) only at two of the three Kb an-
chor residue positions, p5 and p8. Consequently, the TCR
contact residues are all different. Likewise, for the OT-1
TCR, the OVAp ligand (SIINFEKL) bears identity only at
p5 and p8 with CP 1 (ISFKFDHL). Similarly, for the P14
TCR, the lymphocytic choreomeningitis virus gp33–41
peptide (KAVYNFATM) differs from ribonucleotide re-
ductase M1634–642 (FQIVNPHLL) at all positions except for
the p5 anchor residue asparagine. These differences among
peptide ligands mediating positive selection versus their
cognate counterparts argue strongly that positive thymic se-
lection mandates a different set of ligand recognition re-
quirements, at least in terms of the biophysical binding pa-
rameters of TCR–pMHC interaction, than does mature T
cell antigenic recognition.
An important feature of the present findings is that de-
spite the disparity between cognate and selecting peptides,
very few peptides unrelated to the cognate antigen are pos-
itively selecting. Indeed, we observed but 1 out of 80
HPLC thymic peptide fractions to contain positive select-
ing activity for the N15 TCR. Likewise, dulling activity
was detected in only 7–8 out of 100 tumor cell peptide
fractions for the OT-1 TCR. Moreover, NUbO68–75 is
positively selecting for the N15 TCR but not the OT-1
TCR and conversely, the CP -1 peptide, which is posi-
tively selecting for the OT-1, is not positively selecting for
N15 (reference 17 and data not shown). Although the sen-
sitivity of the dulling assay may underestimate the number
of positively selecting thymic peptides because of their low
molarity in the eluted fractions, certainly the number of
positively selecting ligands is finite. Given the primary se-
quence differences between positively selecting and cog-
nate peptides, it is easy to imagine that a number of pep-
tides may be selecting for a single TCR. In the case of the
F5 TCR, as noted above, two distinctly different peptides
are positively selecting in F5 TAP-1 /  FTOC (18, 19).
Hence, a given positively selecting peptide may induce dif-
ferentiation of multiple TCRs during development while a
single antigenic peptide is able to drive activation of a
much more limited number of mature T cells. That a single
peptide can induce polyclonal CD8 SP thymocyte devel-890 Thymic Self-Peptide and Selection
opment in non-tg TAP-1 /  FTOC is consistent with this
notion (23) as is the ability of a single pMHCII complex to
select diverse TCR-bearing CD4 T cells (37–40).
Structural analysis of TCR-pMHC complexes demon-
strate that a majority ( 2/3) of atomic contacts occur be-
tween the TCR and the MHC (41–43). Hence, it is con-
ceivable that “weak” intrinsic TCR–self-MHC reactivity is
the predominant driving force for positive selection. Not-
withstanding, such TCR interaction with  1/ 2 helices of
MHC class I or  1/ 1 helices of MHC class II could be
modulated by the MHC-bound peptide by interposing side
chains that either enhance or diminish TCR interaction
with pMHC. The former peptides may result in negative
selection and the latter in positive selection. Reduction in
affinities of positively selecting Kb-bound peptides relative
to their cognate peptide counterparts by removal of the an-
tigen’s more optimal p1, p4, and/or p6 contacts, for exam-
ple, as in the case of the N15 TCR, may allow for creation
of such a positively selecting ligand. In some cases, intrinsic
contacts between the TCR and MHC alone may be suffi-
cient for selection with no requirement for peptide partici-
pation in recognition whatsoever. Perhaps this is the basis
for detectable SP thymocyte differentiation in N15 tg
RAG-2 /  TAP-1 /  H-2b FTOC (assuming there is not
a TAP-1–independent loading of NUbO68–75 or other se-
lecting peptides). Such a peptide-independent selection
concept has been espoused in the past (44). However,
given the atomic evidence that a local change of the pep-
tide residue can modulate adjacent MHC side chain posi-
tions, thereby amplifying focal local alterations (16), and
the restricted nature of selecting peptides shown collec-
tively in the above studies, it is easiest to imagine that while
TCR–MHC interactions are the driving force for positive
selection, peptides of unrelated sequences to the cognate
ligand when bound to the groove of an MHC antigen-pre-
senting platform will modulate such events.
Finally, as each unique TCR-expressing thymocyte
moves through its microinductive environment, it senses
many different peptides bound to MHC molecules on in-
terdigitating thymic stromal elements. Both the qualitative
nature (affinity) and the quantitative nature (avidity) of
those different pMHC–TCR contacts must be integrated
into the overall selection process. Those TCR-bearing thy-
mocytes which are not deleted via negative selection as a
result of too high an overall avidity for a self-pMHC com-
plex or self-MHC alone can then be positively selected. A
requirement for such a positively selecting peptide is that it
modulates binding of the TCR to a self-pMHC complex
above a threshold so that TCR-stimulated survival signals
can be provided but not so high that TCR-triggered apop-
totic deletion occurs. In the TAP-1 /  FTOC setting,
even a positively selecting peptide ligand at high concen-
tration may surpass the deletion avidity threshold in the ab-
sence of other unrelated self-peptides that would reduce
TCR avidity for the same MHC and result in negative se-
lection. Understanding the precise basis of positive selec-
tion will allow for repertoire manipulation to enhance im-
mune protection in the future.
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